𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.91 THE COURSE OF INFLIXIMAB DISCONTINUATION AFTER LONG-TERM MAINTENANCE THERAPY IN CROHN'S DISEASE

✍ Scribed by A. Armuzzi; M. Rizzi; R. Monterubbianesi; M. Marzo; M. Cicala; L. Guidi; C. Prantera; A. Kohn

Book ID
119633800
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
85 KB
Volume
42
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term outcome of maintenance inflixi
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i

Mucosal healing predicts long-term outco
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease
✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 395 KB πŸ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients

Impact of prior irregular infliximab dos
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease
✍ Daniel J. Stein; Ashwin N. Ananthakrishnan; Mazen Issa; John B. Williams; Dawn B πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 285 KB πŸ‘ 2 views

## Background: Infliximab is efficacious in the management of moderate to severe crohn's disease (cd). there are limited data regarding performance of infliximab in patients who require reinitiation of maintenance dosing following previous irregular exposure. ## Methods: This was a retrospective,